According to the recent findings from Sarink et al. [137] and Rachner et al. [138], it is also possible that OPG circulating concentrations at diagnosis represent a more informative measure for breast cancer prognosis and mortality than OPG expression in tumor tissue. Here, TNFRSF11B is linked to breast cancer.